• Alfa Chemistry, headquartered in New York, USA, stands as a leading provider of drug discovery services. The imperative to combat disease and enhance life and health ranks paramount in societal agendas. At the core of this challenge lies early drug discovery, a realm our scientists have navigated for decades.
• At the forefront of our capabilities is our advanced DNA-encoded libraries (DELs) technology platform. Through this platform, we offer a suite of services encompassing DELs design, synthesis, and selection. Leveraging DELs technology, we facilitate the identification of tractable hit and lead compounds tailored to our clients' pharmaceutical targets.
• Specializing in the discovery and optimization of small molecule drugs, Alfa Chemistry has maintained an unwavering commitment to advancing pharmaceutical science for over two decades. Our expert scientists possess the capability to navigate the entire drug discovery pipeline comprehensively, offering services ranging from hit identification, hit-to-lead, to lead optimization. Moreover, we are equipped to provide tailored services at each stage to meet specific customer requirements.
• Alfa Chemistry boasts a diverse business model, including straightforward pay-for-service options. Guided by a customer-oriented and goal-oriented philosophy, we are dedicated to providing the most reliable and qualified results to our global clientele.

Our Mission, Vision, and Values

✻ Please kindly note that our products and services are for research use only.